David Domzalski
2021
In 2021, David Domzalski earned a total compensation of $4.9M as President and Chief Executive Officer at VYNE Therapeutics, a 69% increase compared to previous year.
Compensation breakdown
| Bonus | $242,910 |
|---|---|
| Option Awards | $2,141,994 |
| Salary | $637,560 |
| Stock Awards | $1,818,861 |
| Other | $11,600 |
| Total | $4,852,925 |
Domzalski received $2.1M in option awards, accounting for 44% of the total pay in 2021.
Domzalski also received $242.9K in bonus, $637.6K in salary, $1.8M in stock awards and $11.6K in other compensation.
Rankings
In 2021, David Domzalski's compensation ranked 2,718th out of 12,415 executives tracked by ExecPay. In other words, Domzalski earned more than 78.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,718 out of 12,415 | 78th |
Division Manufacturing | 1,074 out of 5,505 | 81st |
Major group Chemicals And Allied Products | 422 out of 2,375 | 82nd |
Industry group Drugs | 368 out of 2,096 | 82nd |
Industry Pharmaceutical Preparations | 244 out of 1,546 | 84th |
Source: SEC filing on June 17, 2022.
Domzalski's colleagues
We found two more compensation records of executives who worked with David Domzalski at VYNE Therapeutics in 2021.
News
VYNE Therapeutics CEO David Domzalski's 2023 pay jumps 110% to $2.7M
November 12, 2024
VYNE Therapeutics CEO David Domzalski's 2022 pay falls 73% to $1.3M
November 13, 2023
VYNE Therapeutics CEO David Domzalski's 2021 pay jumps 69% to $4.9M
June 17, 2022
VYNE Therapeutics CEO David Domzalski receives $2.9M in 2020
June 7, 2021